Brazil rejects Dr Reddy's, Cipla GLP-1 generics on technical grounds - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Home industry Brazil rejects Dr Reddy's, Cipla GLP-1 generics on technical grounds

Brazil rejects Dr Reddy's, Cipla GLP-1 generics on technical grounds

industry,

Brazil's regulator Anvisa rejects DRL and Cipla's generic GLP-1 drug filings, citing unmet technical requirements on efficacy, safety and quality

All Copyright @ Trendmergers Team

Crafted With By Templatesyard | Distributed By Gooyaabi Templates